These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 19024375)
1. [Localized prostatic cancer: treatment exclusive by radiotherapy guided by imagery, experiences in Luxembourg in 2005 and 2006]. Untereiner M; Renard-Oldrini S; Mecellem H; Burie D; Lassen Y; Phy RR; Phy SJ; Phy LH Bull Soc Sci Med Grand Duche Luxemb; 2008; (4):559-64. PubMed ID: 19024375 [TBL] [Abstract][Full Text] [Related]
2. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997 [TBL] [Abstract][Full Text] [Related]
3. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237 [TBL] [Abstract][Full Text] [Related]
4. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience. Fonteyne V; Sadeghi S; Ost P; Vanpachtenbeke F; Vuye P; Lumen N; De Meerleer G Acta Oncol; 2015 Jun; 54(6):854-61. PubMed ID: 25387271 [TBL] [Abstract][Full Text] [Related]
5. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity. Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582 [TBL] [Abstract][Full Text] [Related]
6. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer. Vora SA; Wong WW; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK J Urol; 2013 Aug; 190(2):521-6. PubMed ID: 23415964 [TBL] [Abstract][Full Text] [Related]
7. Dose escalation in image-guided, intensity-modulated radiotherapy of carcinoma prostate: initial experience in India. Swamy K; Sathiya Narayanan VK; Basu S; Maiya V; Achari R; Deshpande S; Bhangle J; Gupta KK; Babu N; Pawar S; Atre A; Balachandra K; Koppiker CB J Cancer Res Ther; 2009; 5(4):277-83. PubMed ID: 20160362 [TBL] [Abstract][Full Text] [Related]
8. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785 [TBL] [Abstract][Full Text] [Related]
9. Incremental changes verses a technological quantum leap: the additional value of intensity-modulated radiotherapy beyond image-guided radiotherapy for prostate irradiation. Ratnayake G; Martin J; Plank A; Wong W J Med Imaging Radiat Oncol; 2014 Aug; 58(4):503-10. PubMed ID: 25243269 [TBL] [Abstract][Full Text] [Related]
10. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587 [TBL] [Abstract][Full Text] [Related]
11. Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer. Cheng JC; Schultheiss TE; Nguyen KH; Wong JY Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):351-7. PubMed ID: 18164841 [TBL] [Abstract][Full Text] [Related]
12. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526 [TBL] [Abstract][Full Text] [Related]